Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

199 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Propensity Score Matching Analysis Comparing the Efficacy and Steroid Tapering Benefit of Extracorporeal Photopheresis to Best Available Therapy in Third-Line or Beyond Treatment for Chronic GvHD.
Novitzky-Basso I, Patriquin C, Linn SM, Chiarello C, Pasic I, Lam W, Law A, Michelis FV, Gerbitz A, Viswabandya A, Lipton J, Kumar R, Mattsson J, Barth D, Kim DDH. Novitzky-Basso I, et al. Among authors: viswabandya a. Transplant Cell Ther. 2023 Dec;29(12):773.e1-773.e10. doi: 10.1016/j.jtct.2023.09.021. Epub 2023 Oct 4. Transplant Cell Ther. 2023. PMID: 37797719
High Overall and GVHD-Free Survival in Patients with Aplastic Anemia Receiving in vivo T-cell Depletion Transplants and Long-Term Complications.
Salas MQ, Atenafu EG, Lam W, Law AD, Kim DDH, Michelis FV, Al-Shaibani Z, Gerbitz A, Lipton JH, Viswabandya A, Mattsson J, Gupta V, Kumar R. Salas MQ, et al. Among authors: viswabandya a. Blood Cell Ther. 2020 Jul 14;3(3):48-58. doi: 10.31547/bct-2020-001. eCollection 2020 Aug 25. Blood Cell Ther. 2020. PMID: 36714178 Free PMC article.
Clonal hematopoiesis in the donor does not adversely affect long-term outcomes following allogeneic hematopoietic stem cell transplantation: result from a 13-year follow-up.
Kim KH, Kim T, Novitzky-Basso I, Lee H, Yoo Y, Ahn JS, Pasic I, Law A, Lam W, Michelis FV, Gerbitz A, Viswabandya A, Lipton J, Kumar R, Mattsson J, Zhang Z, Kaushansky N, Brilon Y, Chapal-Ilani N, Biezuner T, Shlush LI, Kim DDH. Kim KH, et al. Among authors: viswabandya a. Haematologica. 2023 Jul 1;108(7):1817-1826. doi: 10.3324/haematol.2022.281806. Haematologica. 2023. PMID: 36727396 Free PMC article.
Mutational profile, outcomes, and impact of allogeneic hematopoietic stem cell transplantation in adult patients with acute myeloid leukemia and inconclusive cytogenetic analysis.
Vasudevan Nampoothiri R, Tang K, Schuh A, Lam W, Maze D, Michelis FV, Chan S, Gupta V, Kim D, Kumar R, Lipton JH, Mattsson J, Minden M, Schimmer A, Sibai H, Viswabandya A, Yee K, Murphy T, Law AD. Vasudevan Nampoothiri R, et al. Among authors: viswabandya a. Eur J Haematol. 2023 Jun;110(6):618-625. doi: 10.1111/ejh.13940. Epub 2023 Feb 16. Eur J Haematol. 2023. PMID: 36732677
Impact of age on hospitalization and outcomes post allogeneic hematopoietic cell transplantation outcome, a single center experience.
Al-Shaibani E, Chen S, Chen C, Pasic I, Michelis FV, Lam W, Law A, Novitzky-Basso I, Gerbitz A, Kim DD, Viswabandya A, Lipton JH, Mattson J, Kumar R. Al-Shaibani E, et al. Among authors: viswabandya a. Ann Hematol. 2023 Apr;102(4):917-926. doi: 10.1007/s00277-023-05135-3. Epub 2023 Feb 23. Ann Hematol. 2023. PMID: 36820907
Interaction Between High-Dose Intravenous Busulfan and Post-Transplantation Cyclophosphamide on Hemorrhagic Cystitis After Allogeneic Hematopoietic Cell Transplantation.
Santos Carreira A, Salas MQ, Remberger M, Novitzky-Basso I, Law AD, Lam W, Pasic I, Mazzulli T, Cserti-Gazdewich C, Kim DDH, Michelis FV, Viswabandya A, Gerbitz A, Lipton JH, Kumar R, Hassan M, Mattsson J. Santos Carreira A, et al. Among authors: viswabandya a. Transplant Cell Ther. 2023 Sep;29(9):581.e1-581.e8. doi: 10.1016/j.jtct.2023.07.007. Epub 2023 Jul 10. Transplant Cell Ther. 2023. PMID: 37437765
Influence of conditioning regimen intensity on outcomes post-allogeneic hematopoietic cell transplantation for acute myeloid leukemia in complete morphological remission.
Alfaro Moya T, Mattsson J, Remberger M, Lipton JH, Kim DD, Viswabandya A, Kumar R, Lam W, Law AD, Gerbitz A, Pasic I, Novitzky-Basso I, Michelis FV. Alfaro Moya T, et al. Among authors: viswabandya a. Eur J Haematol. 2023 Oct;111(4):553-561. doi: 10.1111/ejh.14041. Epub 2023 Jul 18. Eur J Haematol. 2023. PMID: 37461810
Prognostic implication of pre-transplant FEV1 on long-term outcomes following allogeneic hematopoietic stem cell transplantation.
Novitzky-Basso I, Lam W, Chiarello C, Pasic I, Law AD, Michelis FV, Gerbitz A, Viswabandya A, Lipton JH, Kumar R, Mattsson J, Messner HA, Marras TK, Mittoo S, Kim DDH. Novitzky-Basso I, et al. Among authors: viswabandya a. Eur J Haematol. 2023 Nov;111(5):687-696. doi: 10.1111/ejh.14062. Epub 2023 Jul 25. Eur J Haematol. 2023. PMID: 37491877
Choosing Between Older Matched Sibling Donor and Younger Matched Unrelated Donor in Allogeneic Hematopoietic Cell Transplantation: Comparison of Clinical Outcomes in Acute Myeloid Leukemia and Myelodysplastic Syndrome.
Pereira MP, Remberger M, Chen C, Gerbitz A, Kim DDH, Kumar R, Lam W, Law AD, Lipton JH, Michelis FV, Novitzky-Basso I, Viswabandya A, Mattsson J, Pasic I. Pereira MP, et al. Among authors: viswabandya a. Transplant Cell Ther. 2023 Nov;29(11):697.e1-697.e10. doi: 10.1016/j.jtct.2023.08.009. Epub 2023 Aug 12. Transplant Cell Ther. 2023. PMID: 37579919
199 results